{"id":479936,"date":"2024-06-13T11:00:00","date_gmt":"2024-06-13T09:00:00","guid":{"rendered":"https:\/\/innovationorigins.com\/?p=479936"},"modified":"2024-06-13T11:00:00","modified_gmt":"2024-06-13T09:00:00","slug":"ai-boosts-cancer-research-and-successful-spinal-cord-therapy-trial-this-months-bio-snapshot","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/en\/ai-boosts-cancer-research-and-successful-spinal-cord-therapy-trial-this-months-bio-snapshot\/","title":{"rendered":"AI boosts cancer research and successful spinal cord therapy trial: this month&#8217;s BIO+ snapshot"},"content":{"rendered":"\n<p>Like the vitamin shots that line the shelves of your favorite supermarket, IO is preparing a monthly (snap) shot for you with some of the most exciting developments and the most important news about healthcare and agriculture of the past weeks. This month\u2019s main ingredients? New hopes for spinal cord injury patients, AI stepping in for helping to find new tumor treatments, and a fresh round of funding for a company working on peritoneal cancer care. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\">1. ONWARD Medical&#8217;s successful trial <\/h2>\n\n\n\n<p>ONWARD Medical, an Eindhoven-based company, announced the publication of a clinical <a href=\"https:\/\/www.nature.com\/articles\/s41591-024-02940-9\">study<\/a> that tested the capabilities of its electrical stimulation therapy for spinal cord injury patients. The trial, conducted on sixty participants across four countries, showed that 72% of the patients improved in strength and functionality without significant side effects. <\/p>\n\n\n\n<p>Arc-Ex Therapy is an innovative treatment method that uses noninvasive electrical stimulation over the cervical spinal cord. During structured rehabilitation sessions, electrical stimulation is delivered externally through surface electrodes. This helps modulate neuronal activity, improving arm and hand functions in patients with chronic tetraplegia.<\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link\"><a href=\"https:\/\/ioplus.nl\/archive\/en\/onward-medical-provides-breakthrough-treatment-for-patients-with-partial-spinal-cord-injury\/\" class=\"vlp-link\" title=\"ONWARD Medical provides breakthrough treatment for patients with partial spinal cord injury\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">ONWARD Medical provides breakthrough treatment for patients with partial spinal cord injury<\/div><div class=\"vlp-block-1 vlp-link-summary\">A new therapy by ONWARD Medical, which uses electrical stimulation, shows promising results in improving hand and arm function in people with incomplete spinal cord injury. <\/div><\/div><\/div>\n\n\n<h2 class=\"wp-block-heading\">2. AI to the rescue in cancer research<\/h2>\n\n\n\n<p>Research coordinated by the Radboud University Medical Center of Nijmegen shows that AI recognizes prostate cancer better than radiologists. The <a href=\"https:\/\/www.radboudumc.nl\/nieuws\/2024\/ai-beoordeelt-prostaatkanker-op-mri-nauwkeuriger-dan-radiologen\">paper<\/a> demonstrated that the AI model researcher trained can detect about 7% more significant prostate cancer than radiologists. AI outperforms specialists by giving 50% fewer false alarms\u2014signaling suspicious spots that later don&#8217;t turn out to be cancer. This research&#8217;s results will need follow-up studies to be validated. <\/p>\n\n\n\n<p>Meanwhile, scientists at the Erasmus Medical Center in Rotterdam are leveraging AI to study leukemia treatment. The research group led by Prof. Ruud Delwel found a way to <a href=\"https:\/\/amazingerasmusmc.nl\/biomedisch\/ongrijpbare-leukemie-ontrafeld-met-ai\/\">inhibit leukemia cells<\/a> using AI. The scientists found a possible brake to acute myeloid leukemia (AML), a form of cancer in blood-forming cells. Specifically, they used AI models to identify the 3D structures of the proteins that interact when the disease occurs, understanding how they behave and paving the way to develop care to inhibit malicious protein development.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">3. New partnership for healthcare innovations<\/h2>\n\n\n\n<p>Philips and the Maastricht University Medical Center (MUMC+) will <a href=\"https:\/\/www.mumc.nl\/actueel\/nieuws\/maastricht-umc-en-philips-tekenen-4-jarige-strategische-samenwerking#\">collaborate<\/a> on medical innovation development. Specifically, research will be conducted on image-guided treatments (cardiovascular interventions), digitalization of acute and ICU care, and developments in radiology for neurological and oncological care. <\/p>\n\n\n\n<p>A previous example of joint innovation from the two parties is using and developing technology for the\u00a0Philips LumiGuide. In October 2023, MUMC+ was the first hospital in the world to use the Philips LumiGuide for 3D visualization of catheters and guidewires in the body without X-ray during a vascular procedure. This new partnership will explore the application of this technology for other cardiovascular treatments. Philips, MUMC+, and UMC Utrecht previously worked together to develop this technology.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">4. Funding for UPyTher <\/h2>\n\n\n\n<p>UPyTher, a start-up pioneering innovative therapeutics for treating patients with peritoneal cancer, <a href=\"https:\/\/innovationorigins.com\/en\/upyther-attracts-seed-financing-to-advance-the-treatment-of-peritoneal-cancer\/\">raised new funding<\/a> from a group of investors. Peritoneal cancer is an unmet medical need, often contributing to treatment failure and increased mortality rates in patients with colorectal, ovarian, and gastric cancers.<\/p>\n\n\n\n<p>The height of the investment was not disclosed. The investment will enable the preclinical development of UPyTher\u2019s lead product, UPT-211, for treating peritoneal metastases of colorectal cancer and prepare for the first in-patient studies.\u00a0UPyTher aims to establish a new standard in intraperitoneal therapy that offers lifesaving opportunities for patients and makes intraperitoneal therapy simple, safe, and effective.<\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link\"><a href=\"https:\/\/ioplus.nl\/archive\/en\/chemo-gel-shows-promise-in-the-treatment-of-peritoneal-cancer\/\" class=\"vlp-link\" title=\"Chemo-gel shows promise in the treatment of peritoneal cancer\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">Chemo-gel shows promise in the treatment of peritoneal cancer<\/div><div class=\"vlp-block-1 vlp-link-summary\">Each year, more than one million people worldwide contract peritoneal cancer. It is often the result of metastasis from colon, stomach, or ovarian cancer to the peritoneal cavity. <\/div><\/div><\/div>\n\n\n<h2 class=\"wp-block-heading\">5. Crop design powered by AI <\/h2>\n\n\n\n<p>AI is impacting not only cancer research but also plant breeding. Michael Schon, a scientist at Wageningen University, is developing an AI-powered tool to compare non-coding RNA in plant genomes. <a href=\"https:\/\/www.wur.nl\/en\/news-wur\/show-1\/ai-will-unravel-secrets-of-non-coding-genes.htm\">GeneSketch<\/a> is expected to accelerate and empower the development of new plant varieties that can better withstand weather. Although non-coding RNA doesn&#8217;t contain instructions to produce proteins, they are still important to the development of organisms, as they affect their appearance and properties. <\/p>\n\n\n\n<p><em>Do you think we missed something? Contact us at info@innovationorigins.com, and let\u2019s keep the conversation going!<\/em><\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link\"><a href=\"https:\/\/ioplus.nl\/archive\/en\/ai-reshapes-plant-breeding-for-climate-resilient-crops\/\" class=\"vlp-link\" title=\"AI reshapes plant breeding for climate-resilient crops\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">AI reshapes plant breeding for climate-resilient crops<\/div><div class=\"vlp-block-1 vlp-link-summary\">Soon, AI will help us develop new plant varieties. Researchers at Wageningen University are pioneering AI to unlock the secrets of non-coding genes in plants. <\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Like the vitamin shots that line the shelves of your favorite supermarket, IO is preparing a monthly (snap) shot for you with some of the most exciting developments and the most important news about healthcare and agriculture of the past weeks. This month\u2019s main ingredients? New hopes for spinal cord injury patients, AI stepping in [&hellip;]<\/p>\n","protected":false},"author":2589,"featured_media":505830,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[83907],"tags":[69735,10373,85012,50695,52178,71162,39813],"location":[6763],"article_type":[36684],"serie":[],"archives":[],"internal_archives":[],"reboot-archive":[82868],"class_list":["post-479936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bio-en","tag-ai-nl-3","tag-ai","tag-bio-snapshot","tag-erasmus-mc-university","tag-radboudumc-en","tag-radboudumc-2","tag-wageningen-university-research","location-netherlands","article_type-news","reboot-archive-bio"],"blocksy_meta":[],"acf":{"subtitle":"We grouped for you some of the most interesting developments around healthcare and agriculture for the second episode of our BIO+ snapshot.","text_display_homepage":false},"author_meta":{"display_name":"Team IO","author_link":"https:\/\/ioplus.nl\/archive\/author\/erikdevries\/"},"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2024\/06\/gsn4.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">BIO+<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">BIO+<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">AI<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">AI<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">bio+ snapshot<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">Erasmus MC University<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">Radboudumc<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">Radboudumc<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">Wageningen University &amp; Research<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">AI<\/span>","<span class=\"advgb-post-tax-term\">AI<\/span>","<span class=\"advgb-post-tax-term\">bio+ snapshot<\/span>","<span class=\"advgb-post-tax-term\">Erasmus MC University<\/span>","<span class=\"advgb-post-tax-term\">Radboudumc<\/span>","<span class=\"advgb-post-tax-term\">Radboudumc<\/span>","<span class=\"advgb-post-tax-term\">Wageningen University &amp; Research<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on June 13, 2024","modified":"Updated on June 13, 2024"},"absolute_dates_time":{"created":"Posted on June 13, 2024 11:00 am","modified":"Updated on June 13, 2024 11:00 am"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/479936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/2589"}],"replies":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/comments?post=479936"}],"version-history":[{"count":0,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/479936\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/505830"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=479936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=479936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=479936"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=479936"},{"taxonomy":"article_type","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/article_type?post=479936"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/serie?post=479936"},{"taxonomy":"archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/archives?post=479936"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=479936"},{"taxonomy":"reboot-archive","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/reboot-archive?post=479936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}